Once ApolloQD’s technology has been implemented around the world in hospitals, we see a world where the threat of cancer is equal to the threat of the common cold.
By developing quantum dot bioconjugates, we can create a drug delivery system beneficial for treating the highly specific cancer of chronic lymphocytic leukemia that has affected millions.
We realize eradicating cancer can be largely impossible but minimizing the side effects of both cancer and treatment are entirely possible with ApolloQD.
Copyright © 2022 Apollo Therapeutics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.